- Evaluation of Urine NMP22 Point-of-Care Test for the Screening of Bladder Cancer
-
Ihm CH, Kim JM, Sohn YH
- KMID: 1781468
- Korean J Lab Med.
- 2007 Apr;27(2):106-110.
- doi: 10.3343/kjlm.2007.27.2.106
BACKGROUND: Screening of high-risk patients using bladder tumor markers can offer an advantage of early detection and saving medical costs. For these purpose many tumor markers have been developed... -
- CITED
-
- Close
- SHARE
-
- Close
